Levocarnitine recalls

The FDA has published 4 recalls involving Levocarnitine since 2014. The latest was reported on 6 May 2026. Most were for labeling errors. John W Hollis has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls4since 2014
Last 12 months1reported
Class I00% of total
Ongoing2latest 6 May 2026

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 3 75%Class III 1 25%

Why levocarnitine is recalled

By year

Ongoing levocarnitine recalls

2 active
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIILevocarnitine Injection, USP (200 mg/mL) Single-Dose Vial recalledLevocarnitineAmerican RegentLabeling ErrorsNationwide
DrugCLASS IILevocarnitine Oral Solution recalled by AkornAkornPotency & AssayNationwide

All levocarnitine recalls, newest first

4 total

Should you stop taking Levocarnitine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.